Anthem Biosciences Limited — Board Meeting, 19-05-2026: Outcome of Board Meeting

Anthem's board approved Q4 & FY26 consolidated results: full-year net profit hit ₹591.79 Cr (EPS ₹10.55) on ₹2,120.30 Cr revenue. They proposed a ₹2.00/share final dividend and allotted 14.81 lakh ESOP shares. The AGM is scheduled for July 22.